Comparison of the Effects of Aerobic and Resistive Exercises in Female Patients With Rheumatoid Arthritis
1 other identifier
interventional
66
1 country
1
Brief Summary
It is aimed to objectively demonstrate and compare the effectiveness of aerobic and resistant exercises performed on female patients with rheumatoid arthritis with sonographic muscle measurements. In addition, it is planned to compare the effects of 2 group exercises on functional status, quality of life and body composition and to show its correlation with sonographic measurements. There are 3 groups in total in the study. These are the control group given only the range of motion exercise, the second group given the range of motion and resistance exercise, and the third group given the range of motion and aerobic exercise. Exercise programs will last 12 weeks and it is planned to exercise 3 days a week.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable rheumatoid-arthritis
Started Dec 2020
Shorter than P25 for not_applicable rheumatoid-arthritis
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2020
CompletedFirst Posted
Study publicly available on registry
September 30, 2020
CompletedStudy Start
First participant enrolled
December 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2021
CompletedDecember 15, 2022
December 1, 2022
10 months
September 14, 2020
December 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (12)
Ultrasonographic Muscle Size Measurement
Ultrasonographic measurements of transverse muscle thickness will be made in M. Rectus femoris, vastus intermedius, long head of M. biceps femoris and medial head of M. Gastrocnemius. Ultrasonographic measurements will be made at the midpoint between the anterior superior iliac spina and the upper end of the patella for rectus femoris and vastus intermedialis. For the medial head of the gascrokinemius, the measurement will be made at the thickest point where the head of the muscle is in the leg area, and for the biceps femoris muscle, 60% distal between the greater trochanter and the outer femoral condyle and at the intersection point of a line drawn at the midline of the popliteal fossa. While measurements made for rectus femoris and vastus intermedius were evaluated in the supine position; The biceps femoris and gastrocnemius will be evaluated while the patient lies comfortably in the prone position.
at 12th week
5 chair test
In the 5 chair test used in evaluating the functional status of the patient, "The practitioner allows the patient to sit on the chair with his back. The time it takes to sit and get up 5 times is measured with a stopwatch. " It will be made as.
at 12th week
Timed up and go test
In the timed get up and walk test, "3 meters of space is determined in front of the patient sitting on a chair. The patient is asked to get up from the chair, walk this distance and sit down again. Elapsed time is measured with a stopwatch. " It will be applied as.
at 12th week
6-minute walking test
In the 6-minute walking test, "The patient's goal should be to walk the longest distance that he can walk within 6 minutes. The longest distance that the patient can walk after 6 minutes is calculated in meters.
at 12th week
International Physical Activity Scale
Those who score HIGH on the IPAQ engage in * Vigorous intensity activity on at least 3 days achieving a minimum total physical activity of at least 1500 MET minutes a week OR * 7 or more days of any combination of walking, moderate intensity or vigorous intensity activities achieving a minimum total physical activity of at least 3000 MET minutes a week. Scoring a MODERATE level of physical activity on the IPAQ means * 3 or more days of vigorous intensity activity and/or walking of at least 30 minutes per day OR * 5 or more days of moderate intensity activity and/or walking of at least 30 minutes per day OR * 5 or more days of any combination of walking, moderate intensity or vigorous intensity activities achieving a minimum total physical activity of at least 600 MET minutes a week. Scoring a LOW level of physical activity on the IPAQ means that you are not meeting any of the criteria for either MODERATE of HIGH levels of physical activity.
at 12th week
Body Composition Measurements - Muscle
In body composition measurements measured with the DEXA device, total muscle (kg) and their ratio to the total body will be calculated.
at 12th week
Body Composition Measurements - Fat
In body composition measurements measured with the DEXA device, total fat mass according to regions (kg) and their ratio to the total body will be calculated.
at 12th week
Body Composition Measurements - Soft tissue
In body composition measurements measured with the DEXA device, total soft tissue mass (kg) and their ratio to the total body will be calculated.
at 12th week
Short Form - 36
In the evaluation with the short form-36, it is aimed to learn the patient's views about her own health, how she feels and how much she can perform her daily activities. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The lower the score the more disability. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.
at 12th week
Visual Pain Scale
Visual pain scale scored from 0 (no pain) to 10 (maximal pain) will be used in the global pain assessment of the patient.
at 12th week
Fear assessment questionnaire in inflammatory rheumatic diseases
Fear assessment questionnaire in inflammatory rheumatic diseases will be filled. Minimum value is 0, maximum value is 100. Higher score is worse result
at 12th week
Body mass index
Body mass index (weight and height will be combined to report BMI in kg/m\^2) will be calculated.
at 12th week
Study Arms (3)
Range of Motion Exercises
PLACEBO COMPARATORThe patients in the control group will be given the practice of range of motion exercises for 12 weeks, 3 days a week for 50 minutes (1 day accompanied by a physiotherapist).
Range of Motion and Resistive Exercises Group
ACTIVE COMPARATORPatients in this group will be given joint range of motion and resistive exercises with sandbag to the lower extremity for 12 weeks, 3 days a week for 50 minutes (1 day in the presence of a physiotherapist). For the exercises with resistance, the repetition maximum will be calculated and the intensity of the exercises will be adjusted in accordance with the DeLorme protocol.
Range of Motion and Aerobic Exercises Group
ACTIVE COMPARATORJoint range of motion exercises and aerobic exercises on the treadmill will be given to the aerobic exercise arm, 3 days a week for 12 weeks (1 day in the presence of a physiotherapist). For aerobic exercises, the maximum heart rate of the patients will be calculated during exercise and the exercise intensity will be determined by increasing the target heart rate level during the exercise.
Interventions
Resistive exercises with sandbag will be applied 3 times a week for 12 weeks.
Aerobic exercises with treadmill will be applied 3 times a week for 12 weeks.
Range of Motion Exercises will be applied 3 times a week for 12 weeks.
Eligibility Criteria
You may qualify if:
- Romatoid Arthritis diagnosed for\> 1 year
- Female gender
- The patient has been in remission or low disease activity for at least 3 months
- years
You may not qualify if:
- Patient with active arthritis or high disease activity
- Significant deformity and inability to ambulate in the lower extremity joints
- Pregnant patient
- Patient with menopause
- The presence of malignancy
- A patient with a serious psychiatric disorder and difficulty in cooperation
- Presence of cardiovascular and pulmonary comorbidity that may prevent exercise
- Male gender
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Health Sciences, Şişli Hamidiye Etfal Training and Research Hospital
Istanbul, Turkey (Türkiye)
Related Publications (1)
Ayyildiz A, Yilmaz F, Altindas H, Ciftci S, Kuran B. Effects of Aerobic and Resistive Exercise on Muscle Measurements and Body Composition in Female Patients With Rheumatoid Arthritis. Am J Phys Med Rehabil. 2023 Dec 1;102(12):1076-1084. doi: 10.1097/PHM.0000000000002283. Epub 2023 May 10.
PMID: 37204935DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SCREENING
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical Doctor
Study Record Dates
First Submitted
September 14, 2020
First Posted
September 30, 2020
Study Start
December 1, 2020
Primary Completion
September 30, 2021
Study Completion
October 10, 2021
Last Updated
December 15, 2022
Record last verified: 2022-12
Data Sharing
- IPD Sharing
- Will not share